Project Grant R01AG096459
- The National Institute on Aging, part of the Department of Health and Human Services, awarded Weill Medical College of Cornell University $720,523 on June 15, 2026, under the Aging Research program (CFDA 93.866) to evaluate the impact of integrated dual-eligible special needs plans (D-SNPs) on utilization, quality, mortality, and chronic disease management among low-income individuals dually eligible for Medicare and Medicaid who qualify for Medicare based on disability. The study addresses a...
- The National Institute on Aging awarded The University of Chicago $597,239 on September 1, 2026, under the Aging Research program (CFDA 93.866) to support investigation of inpatient rehabilitation facility (IRF) utilization and outcomes for older adult patients with and without Alzheimer's disease or other dementias (ADRD). The research examines comparative value and appropriateness of care delivery across post-acute care settings, specifically comparing higher-cost IRF care—which provides acute...
- The National Institute on Aging awarded Brigham & Women's Hospital $889,734 on September 1, 2026, under the Aging Research program (CFDA 93.866) to advance care planning for older individuals with Down syndrome experiencing early-onset and accelerated dementia. The award funds a mechanistic evaluation of the Serious Illness Care Program (SICP)—a multi-modal intervention comprising a structured conversation guide and clinician training—tailored to older individuals with Down syndrome facing...
- The National Institute on Aging awarded Duke University $678,231 on March 1, 2026, under the Aging Research program (CFDA 93.866) to study the effects of paid family care versus professional aides on Medicaid waiver participants with intellectual and developmental disabilities across the lifespan. The research will use North Carolina's Innovations Waiver as a case study to examine self-directed care using Medicaid administrative data spanning nine or more years. The work comprises three aims:...
- The National Institute on Aging awarded $427,625 to The Washington University on September 1, 2026, under the Aging Research program (CFDA 93.866) to probe cerebellar cortex computations in Alzheimer's disease. The work examines cerebellar nodulus and uvula function in two Alzheimer's disease mouse models—APP/PS1 and 3XTG-AD—at 3, 6, and 12 months of disease progression to assess how hallmarks of Alzheimer's disease contribute to cerebellar dysfunction. The project tests the hypothesis that...
- The National Institute on Aging awarded The Washington University $642,991 on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate genetic drivers of phenotypic variability in autosomal dominant Alzheimer's disease using a multi-omics approach. The research identifies genetic alterations associated with Alzheimer's disease risk and presentation in individuals carrying mutations in the PSEN1, APP, and PSEN2 genes. The project characterizes transcriptomic brain profiles...
- The National Institute on Aging awarded The Johns Hopkins University $769,960 under the Aging Research program (CFDA 93.866) on September 1, 2026, for research examining how changes in home health care agency ownership and private capital investment affect access to care, quality of care, and patient outcomes for people living with dementia. The project, which runs through May 31, 2031, investigates the impact of multi-state chain acquisitions and private capital investments on home health...
- The National Institute on Aging awarded Wake Forest University Health Sciences $633,510 on September 1, 2026, under the Aging Research program (CFDA 93.866) to examine the impact of home-based medical care and telemedicine use on dementia care outcomes among Medicare enrollees with Alzheimer's disease and related dementias. The project will study home-based medical care delivery—house calls by physicians and advanced care providers—and telemedicine use among persons living with Alzheimer's...
- The National Institute on Aging awarded Education Development Center, Inc. $320,150 under the Aging Research program (CFDA 93.866) on September 1, 2026. The research project examines elder mistreatment and self-neglect among older adults with Alzheimer's disease and related dementias, leveraging the UCLA Alzheimer's and Dementia Care (ADC) Program's longitudinal dataset of structured data and clinical notes from dementia care specialists. The study expands the existing dataset to include three...
- The National Institute on Aging awarded the University of Wisconsin – Madison $424,648 on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate ribosome quality control defects in trisomy 21 aging. The project tests a novel hypothesis that premature aging and cellular stress in Down syndrome cells arise from defects in translational fidelity and ribosome quality control caused by chromosome amplification, rather than from specific genes on chromosome 21. The research...
The National Institute on Aging awarded The Washington University $406,707 on September 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to conduct a national longitudinal study examining whether integrated dual-eligible special needs plans improve health outcomes for adults with intellectual disabilities and dementia who are dually enrolled in Medicare and Medicaid. The study addresses the absence of national research on dementia care access, quality, and outcomes among adults with intellectual disabilities, including those with Down Syndrome who face elevated dementia risk and worse health care quality than the general population. Preliminary data indicate approximately 556,893 U.S. adults with intellectual disabilities are enrolled in both Medicare and Medicaid annually, including 53,743 with dementia. The research will assess the adequacy of Medicare and Medicaid coverage models in meeting the needs of aging adults with intellectual disabilities, with particular focus on integrated dual-eligible special needs plans (D-SNPs), in which a single managed care organization coordinates all Medicare services and many or all Medicaid services. The period of performance runs from September 1, 2026, through August 31, 2031. Work is performed in St. Louis, Missouri. The award is classified as a Project Grant under the Trans-NIH Research Support program, which provides research support awards reviewed for scientific merit and program relevance through NIH peer review processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $406.7k | 8/26/26 |